Oakland Park, FL -- November 16, 2015 -- InvestorsHub
NewsWire -- (OTC:
BSEM), Biostem Technologies, Inc. is pleased to announce the
recent purchase of its new research and development lLaboratory and
hHeadquarters building. The building is located at 2836 Center Port
Circle in Pompano Beach, FL. With frontage on I-95 and Copans Road,
CenterPort Business Park is strategically located nearly
equidistant from Fort Lauderdale and Miami, to the south, and Boca
Raton and West Palm Beach, to the north. The purchase price of
Biostems new lLaboratory and hHeadquarters was $600,000 and
projected build-out costs are estimated to be $700,000.The
estimated grand opening for the completed facility is scheduled for
March 1st, 2016.
The architectural design and permitting of Drawings and
permitting process start today of oour new 6,048 sq. ft. facility
is well underway. toinclude a fully developedThe facility will
house a state of the art Level 2 BioSafety Level 2 (BSL-2)
lLaboratory for testing our proprietary wellness and stem cell
productsas well as Biostems Corporate Headquarters. The Center fFor
Disease Control (CDC) describes biosafety levels ranging from BSL-1
to BSL-4. Each biosafety level builds on the controls of the level
before it. Every microbiology laboratory, regardless of biosafety
level follows standard microbiological practices.
*information obtained from CDC.gov
About Biostem Technologies, Inc. (BSEM):
BioStem Technologies (BSEM)
is engaged in the advancementdevelopment of regenerative medicine
and antiaging strategies throughoutin the United States, Europe and
MexicoSouth America. BSEM's ultimate goalmission is to deliver the
highest standard wellness and stem cell products that are backed by
scienceof scientific knowledge and practice for optimal
rejuvenation and wellness through the use of adult stem cells and
Nutraceutical products. Through scientific studies, Wwe seek to
become a world one of the leaders in the wellness arena. This will
be accomplished by using high quality nutraceuticals and stem
cells. newly emerging stem cell research and clinical studies
programs in the United States and in other countries interested in
working with us in this potentially world changing medical
technology. Our state of the artThis lab laboratory is the first
significant step in our quest to introduce the world and our
shareholders our dedication to you and your well-being. our
scientists and our products in development of our vision.
Forward-Looking Statements Except for statements of historical
fact, the matters discussed in this press release are forward
looking and made pursuant to the Safe Harbor provisions of the
Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "future,"
"plan" or "planned,""expects,"believe or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with OTC Markets.
Contact:
Biostem Technologies, Inc.
Phone: 954-380-8342
Website: http://www.biostemtech.com
Email: info@biostemtech.com
Twitter: @Biostemtech
Facebook: https://www.facebook.com/biostemtechnologies